Vitrolife AB (VITR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.021x

Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.021x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr172.00 Million ≈ $18.51 Million USD) by net assets (Skr8.07 Billion ≈ $868.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Vitrolife AB (VITR) defensive interval to measure how many days the company can operate on defensive assets alone.

Vitrolife AB - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Vitrolife AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
M Yochananof and Sons Ltd
TA:YHNF
0.068x
Polestar Automotive Holding UK PLC Class A ADS
NASDAQ:PSNY
0.058x
Tianjin Chase Sun Pharmaceutical Co Ltd
SHE:300026
0.018x
Shandong Yisheng Livestock & Poultry Breeding Co Ltd
SHE:002458
0.021x
Zhiyang Innovation Technology Co. Ltd. A
SHG:688191
-0.026x
Paymentus Holdings, Inc.
NYSE:PAY
0.052x
Zhejiang Huangma Technology Co Ltd
SHG:603181
0.043x
Alimak Hek Group AB
ST:ALIG
0.115x

Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see Vitrolife AB (VITR) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr7.89 Billion
≈ $849.63 Million
Skr635.00 Million
≈ $68.34 Million
0.080x +20.97%
2024-12-31 Skr13.64 Billion
≈ $1.47 Billion
Skr907.00 Million
≈ $97.61 Million
0.066x +11.75%
2023-12-31 Skr12.72 Billion
≈ $1.37 Billion
Skr757.00 Million
≈ $81.47 Million
0.059x +56.60%
2022-12-31 Skr16.74 Billion
≈ $1.80 Billion
Skr636.00 Million
≈ $68.44 Million
0.038x +51.66%
2021-12-31 Skr15.34 Billion
≈ $1.65 Billion
Skr384.31 Million
≈ $41.36 Million
0.025x -85.82%
2020-12-31 Skr2.02 Billion
≈ $217.06 Million
Skr356.45 Million
≈ $38.36 Million
0.177x -23.14%
2019-12-31 Skr1.80 Billion
≈ $193.45 Million
Skr413.33 Million
≈ $44.48 Million
0.230x -1.55%
2018-12-31 Skr1.50 Billion
≈ $161.02 Million
Skr349.44 Million
≈ $37.60 Million
0.234x -8.09%
2017-12-31 Skr1.23 Billion
≈ $132.22 Million
Skr312.19 Million
≈ $33.60 Million
0.254x +43.04%
2016-12-31 Skr1.02 Billion
≈ $109.81 Million
Skr181.26 Million
≈ $19.51 Million
0.178x -22.44%
2015-12-31 Skr844.97 Million
≈ $90.93 Million
Skr193.53 Million
≈ $20.83 Million
0.229x +10.47%
2014-12-31 Skr702.57 Million
≈ $75.61 Million
Skr145.67 Million
≈ $15.68 Million
0.207x -36.98%
2013-12-31 Skr322.60 Million
≈ $34.72 Million
Skr106.13 Million
≈ $11.42 Million
0.329x +53.14%
2012-12-31 Skr278.98 Million
≈ $30.02 Million
Skr59.93 Million
≈ $6.45 Million
0.215x +87.22%
2011-12-31 Skr343.90 Million
≈ $37.01 Million
Skr39.46 Million
≈ $4.25 Million
0.115x -22.63%
2010-12-31 Skr326.33 Million
≈ $35.12 Million
Skr48.40 Million
≈ $5.21 Million
0.148x +11.59%
2009-12-31 Skr312.07 Million
≈ $33.58 Million
Skr41.48 Million
≈ $4.46 Million
0.133x -9.19%
2008-12-31 Skr292.39 Million
≈ $31.47 Million
Skr42.79 Million
≈ $4.61 Million
0.146x +74.23%
2007-12-31 Skr253.38 Million
≈ $27.27 Million
Skr21.29 Million
≈ $2.29 Million
0.084x -22.07%
2006-12-31 Skr220.64 Million
≈ $23.74 Million
Skr23.78 Million
≈ $2.56 Million
0.108x +34.70%
2005-12-31 Skr176.45 Million
≈ $18.99 Million
Skr14.12 Million
≈ $1.52 Million
0.080x -13.96%
2004-12-31 Skr150.57 Million
≈ $16.20 Million
Skr14.01 Million
≈ $1.51 Million
0.093x -57.25%
2003-12-31 Skr143.44 Million
≈ $15.44 Million
Skr31.20 Million
≈ $3.36 Million
0.218x -30.30%
2002-12-31 Skr111.40 Million
≈ $11.99 Million
Skr34.77 Million
≈ $3.74 Million
0.312x --

About Vitrolife AB

ST:VITR Sweden Medical Devices
Market Cap
$1.33 Billion
Skr12.33 Billion SEK
Market Cap Rank
#7869 Global
#114 in Sweden
Share Price
Skr91.05
Change (1 day)
-1.67%
52-Week Range
Skr85.70 - Skr151.30
All Time High
Skr560.50
About

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware … Read more